Retrospective Analysis of Walking Distance and Use of Medication After Bariatric Surgery

Öz

Aim: The objective of this study was to ascertain the drug use and walking distance of individuals after bariatric surgery. Material and Methods: The sample of the study consisted of 165 individuals. Individuals who underwent bariatric surgery were examined retrospectively after their operations. Data were collected using the Personal Information Form and the Walking Impairment Questionnaire. Results: The mean age of the individuals included in the study was 40.22±9.63. 52.1% of individuals were female. The body mass index of individuals was 39.63±4.69 before bariatric surgery and 23.94±2.57 in the first year follow-up after bariatric surgery. Forty percent of individuals did not have any chronic illnesses. Among individuals who had been on medication before surgery, 72.4% of those taking psychiatric medications, 57.5% of those taking diabetes medications, and 16% of those taking heart medications discontinued medications after their operations. 81.8% of individuals reported improved sleep quality compared to the period before the operation. The walking distance level of the individuals showed a significant increase in the first year after bariatric surgery compared to the period before the surgery. Conclusion: The study showed that bariatric surgery is an effective method for weight loss and reduction of comorbidities, as well as leading to a statistically significant reduction in chronic drug use and an increase in sleep quality and walking distance of individuals

Anahtar Kelimeler

• Obese individual
• bariatric surgery
• drug use
• walking distance
• comorbidities associated with obesity

Obezite Cerrahisi Sonrası İlaç Kullanımı ve Yürüme Mesafesi Retrospektif Analizi

Öz

Amaç: Bu araştırma obezite cerrahisi sonrası bireylerin ilaç kullanımının ve yürüme mesafesinin belirlenmesi amacıyla gerçekleştirilmiştir. Gereç ve Yöntemler: Araştırmanın örneklemini 165 birey oluşturmuştur. Obezite cerrahisi olan bireylerin dosyaları retrospektif olarak cerrahi sonrası değerlendirilmiştir. Veriler Kişisel Bilgi Formu ve Yürüme Mesafesinin Azalması Ölçeği ile elde edilmiştir. Bulgular: Araştırma kapsamına alınan bireylerin yaş ortalaması 40.22±9.63’dır. Bireylerin %52.1’ kadındır. Bireylerin obezite cerrahisi öncesi vücut kütle indeksi 39.63±4.69, obezite cerrahisi sonrası 1.yıl kontrolünde ise 23.94±2.57’dır. Bireylerin %40’nın kronik hastalığı yoktur. Ameliyat öncesi ilaç kullanan bireylerden ise; psikiyatrik ilaç kullananların %72.4’ü, diyabet ilacı kullananların %57.5’i ve kalp ilacı kullananların %16’sı ameliyat sonrası ilaç kullanmayı bırakmıştır. Uyku kalitesi ameliyat öncesine göre daha iyi olan bireylerin oranı %81,8’ dir. Bireylerin 1.yıl sonrasında yürüme mesafesi düzeyinin obezite cerrahisi öncesine göre anlamlı düzeyde arttığı saptanmıştır. Sonuç: Obezite cerrahisinin kilo vermede ve komorbiditelerin azalmasında etkili bir yöntem olduğunun yanısıra, bireylerin kronik ilaç kullanımında azalma ve uyku kalitesinde, yürüme mesafesinde artma olduğu istatistiksel olarak anlamlı çıktığı saptanmıştır.

Anahtar Kelimeler

• Obez birey
• obezite cerrahisi
• ilaç kullanımı
• yürüme mesafesi
• obeziteye eşlik eden komorbidite

Kaynakça

1. 1. Jumbe SE. Post-surgical cliff after weight loss surgery: accounts of patients and their health care professionals: University of the West of England; 2017.
2. 2. Dizlek D, Çatal E. Düzce Üniversitesi Bilim ve Teknoloji Dergisi. Morbid obezitede bariatrik cerrahi sonrası hasta sonuçları. 2018;6(2):501-12.
3. 3. Ağagündüz D, Mortaş H, Akbulut G. Bariatrik Ve Metabolik Cerrahide Tıbbi Beslenme Tedavisi-III. 2018.
4. 4. Mitchell JE, King WC, Chen JY, Devlin MJ, Flum D, Garcia L, Inabet W, Pender JR, Kalarchian MA, Khandelwal S. Obesity. Course of depressive symptoms and treatment in the longitudinal assessment of bariatric surgery (LABS‐2) study. 2014;22(8):1799-806.
5. 5. Garver MJ, Focht BC, Dials J, Rose M, Lucas AR, Devor ST, Emery CF, Hackshaw KV, Rejeski WJ. Arthritis. Weight status and differences in mobility performance, pain symptoms, and physical activity in older, knee osteoarthritis patients. 2014;2014.
6. 6. Hayden MJ, Dixon JB, Dixon ME, Shea TL, O’Brien PE. Obesity surgery. Characterization of the improvement in depressive symptoms following bariatric surgery. 2011;21(3):328-35.
7. 7. Sarwer DB, Steffen KJ. Eur Eat Disord Rev. Quality of Life, Body Image and Sexual Functioning in Bariatric Surgery Patients. 2015;23(6):504-8.
8. 8. Marcon ER, Baglioni S, Bittencourt L, Lopes CL, Neumann CR, Trindade MR. Obes Surg. What Is the Best Treatment before Bariatric Surgery? Exercise, Exercise and Group Therapy, or Conventional Waiting: a Randomized Controlled Trial. 2017;27(3):763-73.

9. 9. Baete S, Vercruysse G, Vander Laenen M, De Vooght P, Van Melkebeek J, Dylst D, Beran M, Van Zundert J, Heylen R, Boer W, Van Boxstael S, Fret T, Verhelst H, De Deyne C, Jans F, Vanelderen P. Anesth Analg. The Effect of Deep Versus Moderate Neuromuscular Block on Surgical Conditions and Postoperative Respiratory Function in Bariatric Laparoscopic Surgery: A Randomized, Double Blind Clinical Trial. 2017;124(5):1469-75.
10. 10. Janik MR, Rogula T, Bielecka I, Kwiatkowski A, Paśnik K. Obes Surg. Quality of Life and Bariatric Surgery: Cross-Sectional Study and Analysis of Factors Influencing Outcome. 2016;26(12):2849-55.
11. 11. Ochner CN, Gibson C, Carnell S, Dambkowski C, Geliebter A. Physiol Behav. The neurohormonal regulation of energy intake in relation to bariatric surgery for obesity. 2010;100(5):549-59.
12. 12. Marsk R, Näslund E, Freedman J, Tynelius P, Rasmussen F. Br J Surg. Bariatric surgery reduces mortality in Swedish men. 2010;97(6):877-83.
13. 13. Noah J, Smith A, Birch D, Karmali S. J Minim Invasive Surg Sci. The metabolic effects of laparoscopic sleeve gastrectomy: a review. 2013;2(3):3-7.
14. 14. Vilarrasa N, Rubio MA, Miñambres I, Flores L, Caixàs A, Ciudin A, Bueno M, García-Luna PP, Ballesteros-Pomar MD, Ruiz-Adana M. Obesity surgery. Long-term outcomes in patients with morbid obesity and type 1 diabetes undergoing bariatric surgery. 2017;27(4):856-63.
15. 15. Buchwald H, Oien DM. Obesity surgery. Metabolic/bariatric surgery worldwide 2008. 2009;19(12):1605-11.
16. 16. Eldar S, Heneghan HM, Brethauer SA, Schauer PR. Int J Obes (Lond). Bariatric surgery for treatment of obesity. 2011;35 Suppl 3:S16-21.
17. 17. Richardson DW, Mason ME, Vinik AI. Endocrinol Metab Clin North Am. Update: metabolic and cardiovascular consequences of bariatric surgery. 2011;40(1):81-96, viii.
18. 18. Kwok CS, Pradhan A, Khan MA, Anderson SG, Keavney BD, Myint PK, Mamas MA, Loke YK. Int J Cardiol. Bariatric surgery and its impact on cardiovascular disease and mortality: a systematic review and meta-analysis. 2014;173(1):20-8.
19. 19. Sağlam F, Güven H. Okmeydanı Tıp Dergisi. Obezitenin cerrahi tedavisi. 2014;30(1):60-5.
20. 20. Crujeiras AB, Goyenechea E, Abete I, Lage M, Carreira MC, Martínez JA, Casanueva FF. The Journal of Clinical Endocrinology & Metabolism. Weight regain after a diet-induced loss is predicted by higher baseline leptin and lower ghrelin plasma levels. 2010;95(11):5037-44.
21. 21. Spirou D, Raman J, Smith E. Obesity Reviews. Psychological outcomes following surgical and endoscopic bariatric procedures: a systematic review. 2020;21(6):e12998.
22. 22. Hawkins M, Lee A, Leung S, Hawa R, Wnuk S, Yanofsky R, Sockalingam S. Psychosomatics. Prevalence and Factors Associated With Psychiatric Medication Use in Bariatric Surgery Candidates. 2019;60(5):449-57.
23. 23. Eren İ, Erdi Ö. Klinik Psikiyatri. Obez hastalarda psikiyatrik bozuklukların sıklığı. 2003;6(3):152-7.
24. 24. Özdel O, Sözeri-Varma G, Fenkçi S, Değirmenci T, Karadağ F, Kalkan-Oğuzhanoğlu N, Ateşçi F. Klinik Psikiyatri. Obez kadınlarda psikiyatrik tanı sıklığı. 2011;14(4):210-7.
25. 25. Sjöström L, Narbro K, Sjöström CD, Karason K, Larsson B, Wedel H, Lystig T, Sullivan M, Bouchard C, Carlsson B, Bengtsson C, Dahlgren S, Gummesson A, Jacobson P, Karlsson J, Lindroos AK, Lönroth H, Näslund I, Olbers T, Stenlöf K, Torgerson J, Agren G, Carlsson LM. N Engl J Med. Effects of bariatric surgery on mortality in Swedish obese subjects. 2007;357(8):741-52.
26. 26. Monteiro F, Ponce DAN, Silva H, Pitta F, Carrilho AJF. Obes Surg. Physical Function, Quality of Life, and Energy Expenditure During Activities of Daily Living in Obese, Post-Bariatric Surgery, and Healthy Subjects. 2017;27(8):2138-44.
27. 27. Busetto L, Mozzi E, Schettino AM, Furbetta F, Giardiello C, Micheletto G, Pilone V. Surg Obes Relat Dis. Three years durability of the improvements in health-related quality of life observed after gastric banding. 2015;11(1):110-7.
28. 28. Ersoy E. Obstrüktif Uyku Apnesi Sendromlu Hastalarda Komorbidite ve Obezite Arasındaki İlişki: Kırklareli Üniversitesi Sağlık Bilimleri Enstitüsü; 2019.
29. 29. Andersen JR, Aasprang A, Karlsen T-I, Natvig GK, Våge V, Kolotkin RL. Surgery for Obesity and Related Diseases. Health-related quality of life after bariatric surgery: a systematic review of prospective long-term studies. 2015;11(2):466-73.